Stoke Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Stoke Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2024.
  • Stoke Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $3.17M, a 20.7% increase year-over-year.
  • Stoke Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $12.4M, a 23% increase year-over-year.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $12.4M, a 23% increase from 2023.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $10.1M, a 206% increase from 2022.
  • Stoke Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $3.29M, a 1165% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.4M +$2.32M +23% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $10.1M +$6.79M +206% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $3.29M +$3.03M +1165% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $260K -$541K -67.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $801K -$2.55M -76.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $3.35M +$3.09M +1190% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $260K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.